CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Advanced Viral Research is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Advanced Viral Research
200 Corporate Boulevard South
Phone: (914) 376-7383p:914 376-7383 YONKERS, NY  10701  United States Ticker: ADVRADVR
This company is no longer actively traded on any major stock exchange.
Business Summary
Advanced Viral Research Corp. (Advanced Viral) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. The Company's products may be useful for the treatment of systemic symptoms, such as cachexia (body wasting), loss of appetite and lethargy experienced by patients with advanced malignant cancer, human immunodeficiency virus-acquired immune deficiency syndrome (HIV-AIDS), cardiovascular disease, sepsis, viral infections and other diseases; as an aid in wound healing; as an anti-inflammatory in conditions, such as rheumatoid arthritis, and as a palliative agent to minimize certain toxicities associated with chemo or immunotherapies.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200812/31/2007YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director Stephen M.Elliston 57 5/1/2006 5/1/2006
Secretary MartinBookman 64 3/24/2009 4/20/2004

Business Names
Business Name
Advance Viral Research Ltd.
ADVR
Triad Biotherapeutics, Inc.

General Information
Number of Employees: 7 (As of 12/31/2007)
Outstanding Shares: 880,710,428 (As of 11/13/2008)
Shareholders: 3,530
Stock Exchange: OTC
Federal Tax Id: 592646820
Fax Number: (914) 376-7368


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023